These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 19671308

  • 1. [Effects of glucagon on plasma ghrelin level in type 2 diabetes mellitus].
    Lin SD, Chen ZX, Lin CJ, Duan HY.
    Zhonghua Yi Xue Za Zhi; 2009 Apr 14; 89(14):967-9. PubMed ID: 19671308
    [Abstract] [Full Text] [Related]

  • 2. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M, Bulut K, Hagemann D, Schrader H, Holst JJ, Schmidt WE, Meier JJ.
    Regul Pept; 2006 Dec 10; 137(3):173-8. PubMed ID: 16928403
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.
    Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G.
    Clin Endocrinol (Oxf); 2007 Apr 10; 66(4):593-7. PubMed ID: 17371480
    [Abstract] [Full Text] [Related]

  • 5. [The response of serum ghrelin and PYY to oral glucose and steamed-bread tolerance test in nonobese and obese patients with type 2 diabetes].
    An ZM, Zhang L, Zhang M, Huang MJ, Xiong ZY, Zhang GF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 10; 39(5):772-5. PubMed ID: 19024311
    [Abstract] [Full Text] [Related]

  • 6. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S, Pemberton C, Hunt P, Cole D, Raudsepp S, Inder W.
    Clin Endocrinol (Oxf); 2005 Oct 10; 63(4):412-7. PubMed ID: 16181233
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):669-72. PubMed ID: 19595059
    [Abstract] [Full Text] [Related]

  • 8. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
    Cui T, Ren Y, Ma H, Liu SF, Zhang XX, Yu HL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep 17; 44(5):774-8. PubMed ID: 24325110
    [Abstract] [Full Text] [Related]

  • 9. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
    Albareda M, Rigla M, Rodríguez-Espinosa J, Caballero A, Chico A, Cabezas R, Carreras G, Pérez A.
    Diabetes Res Clin Pract; 2005 Jun 17; 68(3):202-6. PubMed ID: 15936461
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y, Chi Z.
    Zhonghua Yi Xue Za Zhi; 1991 Jan 17; 71(1):16-7, 4. PubMed ID: 1850647
    [Abstract] [Full Text] [Related]

  • 11. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug 17; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 12. The change of plasma ghrelin and leptin levels by the development of type 2 diabetes mellitus in patients with alcohol dependence.
    Ju A, Cheon YH, Lee KS, Lee SS, Lee WY, Won WY, Park SI, Kim WH, Kim DJ.
    Alcohol Clin Exp Res; 2011 May 17; 35(5):905-11. PubMed ID: 21294754
    [Abstract] [Full Text] [Related]

  • 13. Short reaction of C-peptide, glucagon-like peptide-1, ghrelin and endomorphin-1 for different style diet in type 2 diabetic patients.
    Chen Y, Wang X, Zhang MF, Li YX, Li Y, Gu T, Xia FZ, Yu J, Lu YL.
    Chin Med J (Engl); 2011 Nov 17; 124(21):3485-9. PubMed ID: 22340163
    [Abstract] [Full Text] [Related]

  • 14. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K, Lipman TH.
    Pediatr Diabetes; 2007 Apr 17; 8(2):53-9. PubMed ID: 17448127
    [Abstract] [Full Text] [Related]

  • 15. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
    Broglio F, Gottero C, Prodam F, Destefanis S, Gauna C, Me E, Riganti F, Vivenza D, Rapa A, Martina V, Arvat E, Bona G, van der Lely AJ, Ghigo E.
    Clin Endocrinol (Oxf); 2004 Oct 17; 61(4):503-9. PubMed ID: 15473884
    [Abstract] [Full Text] [Related]

  • 16. Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus.
    Oli JM, Adeyemo AA, Okafor GO, Ofoegbu EN, Onyenekwe B, Chukwuka CJ, Chen G, Chen Y, Doumatey AP, Aje TO, Rotimi CN.
    Diabetes Res Clin Pract; 2005 Aug 17; 69(2):196-204. PubMed ID: 16005370
    [Abstract] [Full Text] [Related]

  • 17. [The relationship between oxidative stress and endothelial progenitor cells count in the first-degree relatives of diabetes mellitus].
    Chen SC, Song GY, Sun Y, Liu N.
    Zhonghua Nei Ke Za Zhi; 2012 Mar 17; 51(3):197-200. PubMed ID: 22781892
    [Abstract] [Full Text] [Related]

  • 18. Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.
    Lehtihet M, Efendic S, Brismar K.
    Clin Sci (Lond); 2008 Sep 17; 115(5):167-74. PubMed ID: 18208402
    [Abstract] [Full Text] [Related]

  • 19. Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects.
    Huda MS, Durham BH, Wong SP, Dovey TM, McCulloch P, Kerrigan D, Pinkney JH, Fraser WD, Wilding JP.
    Bone; 2007 Sep 17; 41(3):406-13. PubMed ID: 17613297
    [Abstract] [Full Text] [Related]

  • 20. [Correlation between the amplitude of glucose excursion and plasma 8-iso prostaglandin F2alpha level in subjects with different types of glucose regulation].
    Zheng FP, Wang Z, Li H, Jia CF, Zhang N, Yuan HD.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):651-4. PubMed ID: 19595055
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.